36129098|t|Relationship of serum beta-synuclein with blood biomarkers and brain atrophy.
36129098|a|BACKGROUND: Recent data support beta-synuclein as a blood biomarker to study synaptic degeneration in Alzheimer's disease (AD). METHODS: We provide a detailed comparison of serum beta-synuclein immunoprecipitation - mass spectrometry (IP-MS) with the established blood markers phosphorylated tau 181 (p-tau181) (Simoa) and neurofilament light (NfL) (Ella) in the German FTLD consortium cohort (n = 374) and its relation to brain atrophy (magnetic resonance imaging) and cognitive scores. RESULTS: Serum beta-synuclein was increased in AD but not in frontotemporal lobar degeneration (FTLD) syndromes. Beta-synuclein correlated with atrophy in temporal brain structures and was associated with cognitive impairment. Serum p-tau181 showed the most specific changes in AD but the lowest correlation with structural alterations. NfL was elevated in all diseases and correlated with frontal and temporal brain atrophy. DISCUSSION: Serum beta-synuclein changes differ from those of NfL and p-tau181 and are strongly related to AD, most likely reflecting temporal synaptic degeneration. Beta-synuclein can complement the existing panel of blood markers, thereby providing information on synaptic alterations. HIGHLIGHTS: Blood beta-synuclein is increased in Alzheimer's disease (AD) but not in frontotemporal lobar degeneration (FTLD) syndromes. Blood beta-synuclein correlates with temporal brain atrophy in AD. Blood beta-synuclein correlates with cognitive impairment in AD. The pattern of blood beta-synuclein changes in the investigated diseases is different to phosphorylated tau 181 (p-tau181) and neurofilament light (NfL).
36129098	22	36	beta-synuclein	Gene	6620
36129098	63	76	brain atrophy	Disease	MESH:C566985
36129098	110	124	beta-synuclein	Gene	6620
36129098	155	176	synaptic degeneration	Disease	MESH:D012183
36129098	180	199	Alzheimer's disease	Disease	MESH:D000544
36129098	201	203	AD	Disease	MESH:D000544
36129098	257	271	beta-synuclein	Gene	6620
36129098	401	420	neurofilament light	Gene	4747
36129098	422	425	NfL	Gene	4747
36129098	501	514	brain atrophy	Disease	MESH:C566985
36129098	581	595	beta-synuclein	Gene	6620
36129098	613	615	AD	Disease	MESH:D000544
36129098	627	677	frontotemporal lobar degeneration (FTLD) syndromes	Disease	MESH:D057174
36129098	679	693	Beta-synuclein	Gene	6620
36129098	710	720	atrophy in	Disease	MESH:D001284
36129098	730	735	brain	Disease	MESH:D001927
36129098	771	791	cognitive impairment	Disease	MESH:D003072
36129098	844	846	AD	Disease	MESH:D000544
36129098	903	906	NfL	Gene	4747
36129098	956	990	frontal and temporal brain atrophy	Disease	MESH:D001927
36129098	1010	1024	beta-synuclein	Gene	6620
36129098	1054	1057	NfL	Gene	4747
36129098	1099	1101	AD	Disease	MESH:D000544
36129098	1135	1156	synaptic degeneration	Disease	MESH:D012183
36129098	1158	1172	Beta-synuclein	Gene	6620
36129098	1298	1312	beta-synuclein	Gene	6620
36129098	1329	1348	Alzheimer's disease	Disease	MESH:D000544
36129098	1350	1352	AD	Disease	MESH:D000544
36129098	1365	1415	frontotemporal lobar degeneration (FTLD) syndromes	Disease	MESH:D057174
36129098	1423	1437	beta-synuclein	Gene	6620
36129098	1463	1476	brain atrophy	Disease	MESH:C566985
36129098	1480	1482	AD	Disease	MESH:D000544
36129098	1490	1504	beta-synuclein	Gene	6620
36129098	1521	1541	cognitive impairment	Disease	MESH:D003072
36129098	1545	1547	AD	Disease	MESH:D000544
36129098	1570	1584	beta-synuclein	Gene	6620
36129098	1676	1695	neurofilament light	Gene	4747
36129098	1697	1700	NfL	Gene	4747
36129098	Association	MESH:D012183	6620
36129098	Association	MESH:D001284	6620
36129098	Association	MESH:D003072	6620
36129098	Association	MESH:D001927	6620
36129098	Association	MESH:C566985	6620
36129098	Positive_Correlation	MESH:D000544	6620
36129098	Positive_Correlation	MESH:D001927	4747

